Bluefin Capital Management’s Elevance Health ELV Stock Holding History

Bluefin Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,900	Closed	-$3.2M	–	751
2021 Q4	$3.2M	Buy	+6,900	New	+$2.9M	0.22%	81
2017 Q3	–	Sell	-1,121	Closed	-$211K	–	507
2017 Q2	$211K	Buy	+1,121	New	+$201K	0.02%	329
2017 Q1	–	Sell	-2,147	Closed	-$309K	–	524
2016 Q4	$309K	Buy	+2,147	New	+$287K	0.02%	274
2016 Q2	–	Sell	-8,930	Closed	-$1.24M	–	536
2016 Q1	$1.24M	Buy	+8,930	New	+$1.19M	0.12%	103
2015 Q1	–	Sell	-3,067	Closed	-$385K	–	483
2014 Q4	$385K	Sell	3,067 -124,741	-98%	-$15.4M	0.02%	400
2014 Q3	$15.3M	Buy	127,808 +95,878	+300%	+$11M	0.84%	20
2014 Q2	$3.4M	Buy	+31,930	New	+$3.29M	0.15%	120

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Bluefin Capital Management's ELV Position: Q1 2022 in Review

Bluefin Capital Management sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 6,900 shares — an estimated $3.2M sold.

Bluefin Capital Management first reported a position in ELV in Q2 2014 and held it in 7 quarters. The position peaked at $15.3M in Q3 2014. 1,421 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

Bluefin Capital Management reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
Bluefin Capital Management sold 6,900 Elevance Health shares in Q1 2022, an estimated $3.2M.
Bluefin Capital Management first reported a position in Elevance Health in Q2 2014 and held it in 7 quarters.
Bluefin Capital Management's Elevance Health position peaked at $15.3M in Q3 2014.
1,421 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.